Sionna Therapeutics, Inc. (SION)
4.15
+0.14
(+3.49%)
USD |
NASDAQ |
Oct 20, 16:00
4.145
0.00 (0.00%)
After-Hours: 20:00
Sionna Therapeutics Research and Development Expense (TTM) : 72.04M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 72.04M |
| March 31, 2026 | 65.56M |
| December 31, 2025 | 60.26M |
| September 30, 2025 | 59.35M |
| Date | Value |
|---|---|
| June 30, 2025 | 67.89M |
| March 31, 2025 | 60.74M |
| December 31, 2024 | 57.29M |
| September 30, 2024 | 52.92M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.907B |
| Capricor Therapeutics, Inc. | 98.66M |
| ARS Pharmaceuticals, Inc. | 15.23M |
| ACADIA Pharmaceuticals, Inc. | 331.01M |
| Immunic, Inc. | 90.64M |